Pharmaceuticals

The Rise Of Advancing Pediatric Endocrinology With Extended-Release Innovation Is Influencing The Nucleic Acid Therapeutics Market

May 1, 2026May 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Nucleic Acid Therapeutics Market Projected To Reach By 2030?

The nucleic acid therapeutics market size has experienced substantial expansion in recent years. This market is projected to expand from $6.94 billion in 2025 to $8.01 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 15.4%. Factors contributing to this historical growth include the previously restricted accessibility of nucleic acid therapeutics, the prior dependence on conventional small molecule treatments, a rising need for personalized medicine, successful regulatory clearances for initial gene therapies, and increased academic investigation into gene modulation.

The nucleic acid therapeutics market is projected for swift expansion in the coming years. This market is anticipated to reach $14.07 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 15.1%. This projected growth is driven by advancements in crispr and other gene editing technologies, the broadening use of lipid nanoparticle (lnp) delivery systems, the increasing uptake of personalized nucleic acid therapies, growing partnerships between pharmaceutical and biotechnology companies, and heightened investment in rna-based therapeutics. Key trends during this forecast period encompass the increasing integration of antisense oligonucleotides (asos) and sirna therapies, the expansion of crispr-based and gene editing treatments, the development of targeted therapies for neuromuscular, metabolic, and oncological conditions, greater investment in both non-viral and viral delivery methods, and the emergence of long non-coding rna (lncrna) and microrna (mirna) therapeutics.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27368&type=smp

Which Major Drivers Are Influencing The Expansion Of The Nucleic Acid Therapeutics Market?

The growing incidence of genetic and chronic diseases is anticipated to propel the expansion of the nucleic acid therapeutics market moving forward. These conditions, which include diabetes, cardiovascular diseases, cancer, and autoimmune disorders, illustrate the connection between inherited genetic factors and the development, progression, or susceptibility to long-term health issues. The increase in genetic and chronic diseases is largely attributable to enhanced diagnostic technologies that enable more accurate and earlier identification of these conditions. Nucleic acid therapeutics are beneficial for addressing genetic and chronic diseases because they can target and modify the underlying genetic causes of these conditions by regulating, repairing, or silencing specific genes, thereby offering precise and personalized treatment options. For instance, according to data from October 2024 by the Cystic Fibrosis Trust, a UK-based charity dedicated to supporting people with cystic fibrosis, 11,148 cystic fibrosis patients were registered in 2022, a number that subsequently increased to 11,318 in 2023, reflecting a 1.5% year-over-year rise in patient registrations. Consequently, the increasing number of genetic and chronic diseases is a key factor driving the growth of the nucleic acid therapeutics market.

How Is The Nucleic Acid Therapeutics Market Broken Down By Segment Categories?

The nucleic acid therapeutics market covered in this report is segmented –

1) By Therapy Type: Antisense Oligonucleotides (ASOs), Small Interfering RNA (siRNA), Gene Therapies, Aptamers, Other Therapy Types

2) By Therapeutic Area: Neuromuscular Disorder, Metabolic Disorders, Cardiovascular Disorders, Ophthalmological Disorders, Oncological Disorders, Other Therapeutic Areas

3) By Route Of Administration: Intravenous, Subcutaneous, Other Route Of Administrations

4) By Delivery Method: Viral Vector-Based Delivery Systems, Non-Viral Delivery Systems

5) By End-Use: Pharmaceutical Companies, Government And Academic Research Institutes, Biotech Companies

Subsegments:

1) By Antisense Oligonucleotides (ASOs): Phosphorothioate ASOs, 2’-O-Methyl ASOs, Locked Nucleic Acid (LNA) ASOs, Gapmer ASOs, Morpholino ASOs

2) By Small Interfering RNA (siRNA): Lipid Nanoparticle (LNP) Formulated siRNA, GalNAc-Conjugated siRNA, Chemically Modified siRNA, Naked siRNA

3) By Gene Therapies: Viral Vector-Based Gene Therapy, Non-Viral Vector-Based Gene Therapy, CRISPR-Based Gene Therapy, Zinc Finger Nucleases (ZFNs), TALENs

4) By Aptamers: Ribonucleic Acid (RNA) Aptamers, Deoxyribonucleic Acid (DNA) Aptamers, Spiegelmers, Pegylated Aptamers

5) By Others Therapy Types: MicroRNA (miRNA) Therapeutics, Long Non-Coding RNA (lncRNA) Therapeutics, Ribonucleic Acid (RNA) Editing Therapies, Ribozymes

Which Trends Are Guiding The Direction Of The Nucleic Acid Therapeutics Market?

Major companies operating in the nucleic acid therapeutics market are concentrating on developing innovative products, such as antisense oligonucleotide therapy, which is a precision treatment employing short, synthetic strands of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) to block or modify the expression of specific genes involved in disease. This approach provides targeted treatment options for genetic disorders and rare diseases by silencing their causative genes. For instance, in December 2024, Ionis Pharmaceuticals Inc., a US-based biotechnology company, obtained U.S. Food and Drug Administration (FDA) approval for TRYNGOLZ (olezarsen) as an adjunct therapy to diet for lowering triglyceride levels in adults diagnosed with familial chylomicronemia syndrome (FCS), a rare genetic disorder characterized by severe hypertriglyceridemia (sHTG) and a high risk of acute pancreatitis (AP). TRYNGOLZ represents the first FDA-approved treatment to deliver significant and sustained triglyceride reduction in this patient population, alongside a clinically meaningful decrease in AP incidence when combined with a low-fat diet. The therapy is designed for convenient self-administration via a once-monthly auto-injector.

Which Players Are Present In The Nucleic Acid Therapeutics Market Space?

Major companies operating in the nucleic acid therapeutics market are Pfizer Inc., Novartis AG, Moderna Inc., BioNTech SE, Alnylam Pharmaceuticals Inc., Sarepta Therapeutics Inc., Arrowhead Pharmaceuticals Inc., Arcturus Therapeutics Holdings Inc., CureVac SE, Sangamo Therapeutics Inc., Beam Therapeutics Inc., Arbutus Biopharma Corporation, Silence Therapeutics plc, Copernicus Therapeutics Inc.

Get The Full Nucleic Acid Therapeutics Market Report:

https://www.thebusinessresearchcompany.com/report/nucleic-acid-therapeutics-global-market-report

Which Region Is The Leading Market For The Nucleic Acid Therapeutics Market?

North America was the largest region in the nucleic acid therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nucleic acid therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Nucleic Acid Therapeutics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/nucleic-acid-therapeutics-global-market-report

Browse Through More Reports Similar to the Global Nucleic Acid Therapeutics Market 2026, By The Business Research Company

Sandwich Panels Market Report 2026

https://www.thebusinessresearchcompany.com/report/sandwich-panels-global-market-report

Structural Insulated Panels Market 2026

https://www.thebusinessresearchcompany.com/report/structural-insulated-panels-market

Metal Structural Insulation Panels Market Report 2026

https://www.thebusinessresearchcompany.com/report/metal-structural-insulation-panels-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795